Evidence map›Paper›PMID 27621222›Full record

ArticleExperimental dermatology2017

Molecular and histological characterization of age spots.

Wonseon Choi, Lanlan Yin, Christoph Smuda, Jan Batzer, Vincent J Hearing, Ludger Kolbe

Abstract read
In one paragraph

Article in Experimental dermatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. In Vitro Anti-Aging Properties of aMolecules (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Disrupting melanin transfer: innovative strategy for anti-pigmentation drug discovery.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  8. Lipidome Complexity in Physiological and Pathological Skin Pigmentation.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. miR-4521-A novel biomarker for human lentigos.Experimental dermatology · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Skin Pigmentation Types, Causes and Treatment-A Review.Molecules (Basel, Switzerland) · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Wonseon ChoiLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Lanlan YinLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Christoph SmudaR&D Front End Innovation, Beiersdorf AG, Hamburg, Germany.
Jan BatzerR&D Front End Innovation, Beiersdorf AG, Hamburg, Germany.
Vincent J HearingLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Ludger KolbeR&D Front End Innovation, Beiersdorf AG, Hamburg, Germany.
Beiersdorf (Germany) · DENational Cancer Institute · US

Funding

Characterization of Pigmentary Disorders and Melanoma TargetingZIABC010785 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HEARING, VINCENT J · 2009 to 2014
$3.0M
Intramural NIH HHS ZIA BC010785
6 · The paper itself

Abstract

Age spots, also called solar lentigines and lentigo senilis, are light brown to black pigmented lesions of various sizes that typically develop in chronically sun-exposed skin. It is well known that age spots are strongly related to chronic sun exposure and are associated with photodamage and an increased risk for skin cancer; however, the mechanisms underlying their development remain poorly understood. We used immunohistochemical analysis and microarray analysis to investigate the processes involved in their formation, focusing on specific markers associated with the functions and proliferation of melanocytes and keratinocytes. A total of 193 genes were differentially expressed in age spots, but melanocyte pigment genes were not among them. The increased expression of keratins 5 and 10, markers of basal and suprabasal keratinocytes, respectively, in age spots suggests that the increased proliferation of basal keratinocytes combined with the decreased turnover of suprabasal keratinocytes leads to the exaggerated formation of rete ridges in lesional epidermis which in turn disrupts the normal processing of melanin upwards from the basal layer. Based on our results, we propose a model for the development of age spots that explains the accumulation of melanin and the development of extensive rete ridges in those hyperpigmented lesions.

Indexed as

MelanocytesAgedCytoprotectionHumansKeratin-10Keratin-5KeratinocytesLentigoMelaninsMiddle AgedModels, BiologicalSkin AgingTranscriptomeKeratin-10Keratin-5KRT10 protein, humanKRT5 protein, humanMelaninslentigo senilismelaninpigmentationskinsolar lentigo

Identifiers

PMID27621222
PMCPMC5342934
OpenAlexW2519643340

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.